Abstract
Rationale
The dopamine D3 receptor has been extensively studied in animal models of drug abuse and psychosis; however, less is known on its possible role in cognitive functions.
Objectives
This study investigated the effects of different D3 antagonists and a partial agonist on spatial learning performance in a water labyrinth test.
Methods
Rats had to swim through a labyrinth system by making correct directional turns at three choice-points. The number of errors was recorded in three daily trials for 3 days.
Results
D3 antagonists such as the highly selective SB-277011 (24 mg/kg p.o.) and RGH-1756 (1 mg/kg p.o.), the moderately selective U-99194A (12 mg/kg s.c.) and the selective partial D3 agonist BP-897 (1 mg/kg i.p.) all significantly attenuated the learning deficit caused by FG-7142. Against scopolamine-induced amnesia, SB-277011 (24 mg/kg p.o.) was equally potent in showing protective efficacy; however, two times higher dose levels of U-99194A (24 mg/kg s.c.) and RGH-1756 (2 mg/kg p.o.) were required to attenuate the scopolamine-induced impairment. In contrast to the full antagonists, against scopolamine-induced amnesia, the partial agonist BP-897 (2 mg/kg i.p.) was inactive, even at the two times higher dose level.
Conclusions
These data suggest that dopamine D3 receptor antagonists possess cognition-enhancing activity which may be of benefit in the treatment of cognitive dysfunction associated with several psychiatric disorders.
Similar content being viewed by others
References
Arnsten AF, Cai JX, Steere JC, Goldman-Rakic PS (1995) Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys. J Neurosci 15:3429–3439
Audinot V, Newman-Tancredi A, Gobert A, Rivet JM, Brocco M, Lejeune F, Gluck L, Desposte I, Bervoets K, Dekeyne A, Millan MJ (1998) A comparative in vitro and in vivo pharmacological characterisation of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287:187–197
Barik S, de Beaurepaire R (1998) Hypothermic effects of dopamine D3 receptor agonists in the island of Calleja magna. Potentiation by D1 activation. Pharmacol Biochem Behav 60:313–319
Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten FT (1999) A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 46:1266–1274
Bubser M and Schmidt WJ (1990) 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res 37:157–168
Gasbarri A, Introini-Collison IB, Packard MG, Pacitti C, McGaugh JL (1993) Interaction of cholinergic–dopaminergic systems in the regulation of memory storage in aversively motivated learning tasks. Brain Res 627:72–78
Glickstein SB, Hof PR, Schmauss C (2002) Mice lacking dopamine D2 and D3 receptors have spatial working memory deficits. J Neurosci 22:5619–5629
Hersi AJ, Rowe W, Gaudreau P, Quirion R (1995) Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69:1067–1074
Horváth A, Kiss B, Laszlovszky I, Bugovics G, Domány G, Szombathelyi Z (2001) Functional characterization of RGH-1756, a highly selective dopamine D3 antagonist. Eur J Pharm Sci 13:S22
Karreman M, Moghaddam B (1996) Effect of a pharmacological stressor on glutamate efflux in the prefrontal cortex. Brain Res 716:180–182
Kiss B, Laszlovszky I, Auth F (2000) Neurochemical characterization of RGH-1756, a potent ligand of dopamine D3 receptors. Int J Neuropsychopharmacol 3(Suppl 1):S135
Lacroix LP, Hows MEP, Shah AJ, Hagan JJ, Heidbreder C (2003) Selective agonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology 28:839–849
Laszlovszky I, Ács T, Kiss B, Domány G (2001) Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands. Pharmazie 56:287–289
Le Foll B, Schwartz JC, Sokoloff P (2000) Dopamine D3 receptor agents as potential new medications for drug addiction. Eur Psychiatry 15:140–146
Levin ED, McGurk SR, Rose JE, Butcher LL (1990) Cholinergic–dopaminergic interactions in cognitive performance. Behav Neural Biol 54:271–299
Levin ED, Eisner B (1994) Nicotine interactions with D1 and D2 agonists: effects on working memory function. Drug Dev Res 31:32–37
Moore H, Stuckman S, Sarter M, Bruno JP (1995) Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling. Synapse 21:324–331
Moore H, Fadel J, Sarter M, Bruno JP (1999) Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience 88:811–822
Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH (1996a) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci U S A 93:1325–1329
Murphy BL, Arnsten AFT, Jentsch JD, Roth RH (1996b) Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci 16:7768–7775
Murphy BL, Robert MS, Roth H, Armsten AFT (1997) Clozapine reverses the spatial working memory deficits induced by FG7142 in monkeys. Neuropsychopharmacology 16:433–437
Murray AM, Ryoo HL, Gurevich E, Joyce JN (1994) Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci U S A 91:11271–11275
Myhrer T (2003) Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Rev 41:268–287
Ninan I, Kulkarni SK (1999) Effect of olanzapine on behavioural changes induced by FG-7142 and dizocilpine on active avoidance and plus maze tasks. Brain Res 830:337–344
Paróczai M, Kiss B, Kárpáti E (1998) Effect of RGH-2716 on learning and memory deficits of young and aged rats in water-labyrinth. Brain Res Bull 45:475–488
Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, Sokoloff P (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400:371–375
Reavill C, Taylor SG, Wood MD, Ashmeade T, Austin NE, Avenell KY, Boyfield I, Branch CL, Cilia J, Coldwell MC, Hadley MS, Hunter AJ, Jeffrey P, Jewitt F, Johnson CN, Jones DNC, Medhurst AD, Middlemiss DN, Nash DJ, Riley GJ, Routledge C, Stemp G, Thewlis KM, Trail B, Vong AKK, Hagan JJ (2000) Pharmacological actions of a novel, high-affinity, and selective human dopamine D3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294:1154–1165
Sarter M, Bruno JP, Berntson GG (2001) Psychotogenic properties of benzodiazepine receptor inverse agonists. Psychopharmacology (Berl) 156:1–13
Sato K, Ueda H, Okumura F, Misu Y (1994) 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats. Brain Res 655:233–236
Schwartz JC, Diaz J, Bordet R, Griffon N, Perachon S, Pilon C, Ridray S, Sokoloff P (1998) Functional implication of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Res Rev 26:236–242
Schwartz JC, Diaz J, Pilon C, Sokoloff P (2000) Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions. Brain Res Rev 31:277–287
Seamans JK, Floresco SB, Phillips AG (1998) D1 receptor modulation of hippocampal–prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 18:1613–1621
Sigala S, Missale C, Spano P (1997) Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat. Eur J Pharmacol 336:107–112
Smith AG, Neill JC, Costall B (1999) The dopamine D3/D2 receptor agonist 7-OH-DPAT induces cognitive impairment in the marmoset. Pharmacol Biochem Behav 63:201–211
Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146–151
Ukai M, Tanaka T, Kameyama T (1997) Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice. Eur J Pharmacol 324:147–151
Umegaki H, Munoz J, Meyer RC, Spangler EL, Yoshimura J, Ikari H, Iguchi A, Ingram DK (2001) Involvement of dopamine D2 receptors in complex maze learning and acetylcholine release in ventral hippocampus of rats. Neuroscience 103:27–33
Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A (1993) The dopamine D3 receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm Gen Sect 94:11–19
Wilkerson A, Levin ED (1999) Ventral hippocampal dopamine D1 and D2 systems and spatial working memory in rats. Neuroscience 89:743–749
Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575
Zahrt J, Taylor JR, Mathew RG, Arnsten AFT (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 17:8528–8535
Acknowledgements
The authors thank Mrs. Csilla Nagy and Mrs. Tünde Féth for their careful technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Laszy, J., Laszlovszky, I. & Gyertyán, I. Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology 179, 567–575 (2005). https://doi.org/10.1007/s00213-004-2096-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-2096-z